◆ TICKERBASEVisão interativa →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Início › Todas as ações › 3349 · English version

COSMOS Pharmaceutical Corporation (3349)

Histórico de receita, lucros e fluxo de caixa das demonstrações financeiras oficiais.

Healthcare · Wall Street (EUA) · Última atualização: 2026-09-30

COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, and food products in Japan. The company offers general medicines, energy drinks, oral and nursing care products, vitamins, health foods, diet foods, and prescriptions; and hair care and bath products.

Números-chave

Ver gráficos interativos e demonstrações completas → Modelo de avaliação (DCF) →

Demonstração de resultados anual

Demonstração de resultados2026-05-312025-05-312024-05-312023-05-312022-05-31
Receita totalJPY 1.10TJPY 1.01TJPY 965.0BJPY 827.7B—
Lucro brutoJPY 229.7BJPY 213.3BJPY 188.3BJPY 168.7B—
Resultado Operacional (EBIT)JPY 42.4BJPY 40.4BJPY 31.5BJPY 30.1B—
Resultado líquidoJPY 32.0BJPY 31.0BJPY 24.5BJPY 23.8B—

Fonte: relatórios públicos da empresa (SEC). Verifique no SEC EDGAR antes de confiar em qualquer número.

Balanços, fluxos de caixa, dados trimestrais e indicadores completos no visualizador interativo de 3349. /companies/us/3349

Empresas semelhantes

As informações deste site são apenas educacionais e informativas; não constituem recomendação de investimento. Não publicamos preços-alvo nem recomendações.

English version →Todas as ações

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.